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Abstract
In inner organs, glutamine contributes to proliferation, detoxification and establishment of a mechanical barrier, i.e.,
functions essential for skin, as well. However, the age-dependent and regional peculiarities of distribution of glutamine
synthetase (GS), an enzyme responsible for generation of glutamine, and factors regulating its enzymatic activity in
mammalian skin remain undisclosed. To explore this, GS localization was investigated using immunohistochemistry and
double-labeling of young and adult human and rat skin sections as well as skin cells in culture. In human and rat skin GS was
almost completely co-localized with astrocyte-specific proteins (e.g. GFAP). While GS staining was pronounced in all layers
of the epidermis of young human skin, staining was reduced and more differentiated among different layers with age. In
stratum basale and in stratum spinosum GS was co-localized with the adherens junction component ß-catenin. Inhibition of,
glycogen synthase kinase 3b in cultured keratinocytes and HaCaT cells, however, did not support a direct role of ß-catenin
in regulation of GS. Enzymatic and reverse transcriptase polymerase chain reaction studies revealed an unusual mode of
regulation of this enzyme in keratinocytes, i.e., GS activity, but not expression, was enhanced about 8–10 fold when the cells
were exposed to ammonium ions. Prominent posttranscriptional up-regulation of GS activity in keratinocytes by
ammonium ions in conjunction with widespread distribution of GS immunoreactivity throughout the epidermis allows
considering the skin as a large reservoir of latent GS. Such a depository of glutamine-generating enzyme seems essential for
continuous renewal of epidermal permeability barrier and during pathological processes accompanied by hyperammo-
nemia.
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Introduction
Glutamine synthetase (GS; EC 6.3.1.2) is the only known
human enzyme capable of catalyzing glutamine (Gln) synthesis
from ammonia and glutamate and, thereby, contributes to
multiple tissue events regulated by this amino acid. Gln represents
the most abundant amino acid in mammalian blood reflecting its
function as the major shuttle of amino-nitrogen between cells. It
plays an important role in acid-base homeostasis and serves as a
fuel source for many types of cells. In rapidly dividing cells GS is
required as a precursor for the synthesis of multiple biologically
active compounds including purines, pyrimidines, and aminosu-
gars [1]. Last but not least, Gln is a major constituent of proteins
particularly in skin.
GS is found in many, if not all organs [2]. However, in most
of them, expression of GS is confined to specific cell populations
only. Prominent examples for this are the pericentral hepatocytes
in liver [3,4] and certain cells lining the proximal convoluted
tubules in kidney [2,5,6]. In addition, GS at a lower but highly
adaptive level is expressed in almost every organ in glial fibrillary
acidic protein (GFAP)-producing perivascular cells that play an
important role in tissue homeostasis at the blood-tissue interface
[7]. These cells comprise astrocytes located at the blood brain
barrier [8], activated hepatic stellate cells (HSC) at the blood-
tissue interface in liver [9], and Leydig cells of the testis [10]. In
pathological conditions, on the other hand, GS may be
expressed in cells that normally do not produce the enzyme,
such as neurons in Alzheimers disease. [11,12,13]. Thus, the
cellular expression of GS in each organ is highly specific and has
to be characterized by immunocytochemistry or similar tech-
niques, in order to draw conclusions on its precise role and
function.
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4416Compared to many other organs, GS activity in rat skin has
been found to be rather moderate [14,15]. Consequently, interest
in GS in skin remained low for a long time and this organ was not
even mentioned in a comprehensive survey on GS in murine
organs [16]. Even less is known so far about the cellular
distribution as well as the specific function of GS in this organ.
However, recent observations on humans with inherited GS
deficiency convincingly showed the importance of GS for skin-
specific functions. The consequences of this metabolic disease were
illustrated by severely disturbed epidermal development, rapid
appearance of focal erythema and blistering of the integumentum
resulting in early postnatal death [17,18]. These findings
concerning integrity, regeneration and molecular characteristics
of human and rodent skin propose a previously unrecognized
considerable demand for Gln in the developing skin and an
important local function of GS in skin integrity. An increased need
for Gln during skin regeneration was also suggested by the finding
that major burn injury of skin leads to the induction of GS
expression in specific tissues such as lung, muscle, kidney and liver
[19]. Likewise, thermal injury of 33–35% of body surface area is
accompanied by increased levels of Gln in muscle, skin and
adipose tissue preparations [20]. These studies call for detailed
investigation of distribution of GS in different cell types and
structures of the skin as well as mechanisms involved in the
regulation of GS levels in keratinocytes.
Multiple structural and functional peculiarities and specific
anatomy of the skin, offered an interesting object for further
examination of our hypothesis concerning commonness of
mechanisms operating at the border of different environments
and tissues, i.e., blood-tissue, blood-urine and air-tissue interfaces.
The co-localization in skin cells of several astrocyte-specific
antigens [21] considerably strengthen our viewpoint concerning
the universality of mechanisms regulating the homeostasis in
different organs. This raised the question of whether the peculiar
ability of smooth muscle alpha-actin (SMAA) and GFAP-
containing astrocytes and HSC to express GS in a dynamic
fashion contributing to tissue homeostasis and protection [7,9,22–
24] may be found as well in epidermal keratinocytes forming part
of the tissue-air interface.
To learn more about the skin-specific functions of GS we have
investigated in detail the distribution of GS in different cell types
and structures in human and rat skin samples of different age. In
accordance with studies demonstrating a dependency of the
antigenic composition of skin cells on their anatomy and age
[25,26], the specific cellular expression and localization of GS in
different skin samples of humans and rats showed some variation
depending on the age of the donor and on the location from which
the skin sample was taken. These variations, for which we provide
some prominent examples for different parts of skin from children
and adult humans as well as from newborn and adult rats, indicate
a close association of the specific cellular localization of GS with
different functional and structural features of skin. In order to
emphasize this association and, at the same time, to illustrate
possible exceptions, we performed co-localizations of GS with each
of the marker proteins previously shown to characterize these
functional and structural differences [21]. Furthermore, we aimed
at elucidating basic mechanisms involved in the regulation of GS
levels in skin keratinocytes. In the light of recent in vitro studies
demonstrating the influence of Gln on establishment of adherens
and tight junctions complexes [27–30] and of the novel role of
wingless-type mouse mammary tumour virus integration site
family member (Wnt)/b-catenin signaling in regulating GS
expression in liver [31], a series of investigations has been
performed to examine the relation between GS and b-catenin.
Our results suggest multiple roles of GS in maintaining barrier
structure and function of skin supported by novel specific
regulatory features.
Results
Cellular localization of GS in skin
Distribution of GS and its co-localization with GFAP and
SMAA in human skin slices. Double labeling of sections of
human foreskin with polyclonal antibodies (pAb) directed against
GS (green, Figure 1A) and monoclonal antibodies (mAb) against
bovine GFAP (red, Figure 1B) revealed almost complete co-
localization of both proteins in all layers of the epidermis: stratum
basale (magenta arrows throughout Figure 1), stratum spinosum,
stratum granulosum and stratum corneum (blue arrows
throughout Figure 1). Similar spatial distribution of GS and
GFAP was illustrated by intense yellow staining of epidermis in
merged micrographs (Figure 1C). In young foreskin, the stratum
corneum is very thin. The reaction of GS was particularly strong
in stratum granulosum and stratum corneum and slightly weaker
in stratum basale and stratum spinosum. In the dermis of these
skin samples (white arrows), GS was expressed weaker than in
epidermis (cf. structures indicated by blue and white arrows in
Figures 1A, C). Similar findings for GS were obtained also in older
foreskin (not shown).
In skin sections double-labeled with antibodies against GS and
anti-SMAA, occasionally enhancement of GS staining in the
nuclear area of the keratinocytes located in inner layers of the
epidermis could be seen (Figure 1D). In accordance with our
recent study [21], SMAA (Figure 1E, red) was preferentially
localized in the perinuclear and nuclear area of human foreskin
keratinocytes resulting in yellow or orange staining of this area in
merged micrographs (Figure 1F). The line drawn through
Figures 1D, E, F, clearly demarcates the highest accumulation of
SMAA expressing cells in the stratum granulosum and its absence
in stratum corneum of young human foreskin (Figure 1E) which
strongly stained for GS (Figure 1D). GS and SMAA were both
present in stratum granulosum and inner parts of epidermis
(Figure 1F). In foreskin dermis, on the other hand, SMAA (red,
Figure 1E) could barely be detected in fibroblasts moderately and
evenly expressing GS (green, Figures 1A, C, D, F). Instead, it was
strongly expressed in myofibroblasts surrounding the middle-sized
vessels (yellow arrows in Figure 1E, F) and in the papillary zone of
the dermis in which GS was poorly presented (orange staining in
merged Figure 1F). GS and SMAA were also co-localized in
association to large vessels situated in the reticular part of the
dermis (not shown).
Co-localization of GS and b-catenin in aged human temple
skin. Since the Wnt/ß-catenin signalling pathway was recently
found to play an important role in the regulation and zonal
expression of GS in liver [31,32] we wondered whether ß-catenin
might be co-localized with GS in skin as well. Figure 2A shows
conventional eosin staining of temple skin of aged (70-year-old)
male patient. Immunohistological staining of this region of aged
skin with a monoclonal anti-GS-antibody and peroxidase (POD)-
coupled secondary antibodies revealed the presence of GS in
epidermis (Figure 2B). In aged human temple skin, the staining for
GS was especially strong in stratum granulosum, while it was
almost absent from the utmost layer of stratum corneum. b-
catenin, was relatively strongly expressed in cells of stratum basale
and stratum spinosum (Figure 2C). In stratum granulosum the
intensity of b-catenin staining abruptly decreased. Some
keratinocytes expressed b-catenin preferentially in the
membranes and slightly in the cytoplasm but not in the nucleus,
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be observed. The heterogeneity in staining for b-catenin and its
intercellular localization may be explained by differences in the
individual rates of differentiation of keratinocytes, as well as by
region-specific requirements. Remarkably, GS (at a moderate
level) and b-catenin were both present in stratum basale, the actual
proliferative compartment, and in stratum spinosum.
Age-specific and regional distribution of GS and GFAP in
rat skin. When skin samples of newborn and adult rats were
compared, it became obvious that immediately after birth GS is
strongly expressed in stratum basale of rat scalp and much less
intense in dermal fibroblasts as shown by confocal laser scanning
(CLS) micrographs of newborn rat scalp sections (white arrows
Figure 3A, B). In hair follicles of newborn rat scalp, GS was
prominent in the outer sheet and in the medulla (red arrows in
Figures 3E–G). CLS microscopy of culture-activated fibroblasts
isolated from young human skin showed strong reaction of GS in
cytoplasm and especially nuclei of the cells (yellow arrows in
Figures 3D, H).
After few days, i.e., in 2–3-day-old rat scalp sections GS was
found in all layers of epidermis. GS expression (green) was
significantly increased in stratum granulosum (magenta arrows in
Figure 4A–C) and was present in corneocytes in some regions of
stratum corneum (yellow arrows Fig 4A–C) which at that time still
contained many nuclei or nuclear remnants revealed by 49,6
diamidino-2-phenylindole (DAPI) staining. At this age, co-
localization of GS (green) with GFAP (red) in stratum corneum
was less prominent than in stratum granulosum (cf. magenta and
yellow arrows in Figure 4C). By contrast, in adult rat scalp staining
intensity of GS at the interface of stratum granulosum and stratum
corneum decreased (Figure 4D), whereas in the same region GFAP
dominated (white arrows in merged Figure 4F). In adult rat scalp
sections, the number of nuclear remnants in stratum corneum was
strongly decreased compared to aged skin in humans. Though this
type of co-localization of GS and GFAP was preserved in other
skin samples of adult rats, for instance in leg skin (Figure 4G–L),
the ratio between GS (green) and GFAP (red) seemed to vary
slightly depending on whether samples from lateral (Figure 4G–I)
or medial (Figure 4J–L) leg skin were stained. Thus, in the lateral
surface of the leg skin many regions lacking GS (white arrows in
Figure 4G–I) could be found, whereas in medial surface of the leg
skin the GS/GFAP ratio was significantly increased (red arrows in
Figure 4G–L).
Co-localization of GS and metallothionein in skin slices
and cultured cells. The pattern of staining for metallothionein
(MT) in newborn rat scalp (Figure 5A, B) was different from that of
in human skin described previously [21]. In human skin,
keratinocytes strongly expressing MT in all layers of epidermis
exhibited widespread co-localization with GS. By contrast, in
newborn rats, the only region of the epidermis reacting with mAb
MT (red) was the stratum basale (magenta arrows in Figure 5A).
Only in this layer of epidermis, GS (green) showed some co-
localization with MT. In rat scalp skin dermis, GS and MT were
localized in functionally different dermal cells. MT (red) was
evenly distributed in GS-negative fibroblasts throughout the
dermis (white arrows in Figures 5A, B), whereas GS was
prominent in the outer sheet (green arrows in Figure 5A, B) and
medulla of hair follicles (red arrows in Figure 5A, B). Though
weakly, GS was also expressed in the sweat glands (yellow
arrowheads in Figure 5B). MT and GS were also present in
germinative epidermal cells located in the lower end bulb region of
rat hair follicles (yellow arrows in Figure 5B).
Figure 1. Presence of GS in human foreskin of children and regional variations in its distribution revealed in co-localization studies
with GFAP, or with SMAA. (A–D) Expression of GS (A) and GFAP (B) and merged micrograph of GS and GFAP (C) immune reaction in human
foreskin sections. (D–F) Expression of GS (D) and SMAA (E) and merged micrograph of GS and SMAA immune reaction (F) in a human skin section. The
line connecting the D–F clearly shows strong expression of SMAA (E) in stratum granulosum and its absence of stratum corneum. The latter is
strongly stained for GS (D). GS and SMAA merge at the interface of stratum corneum boarder and stratum granulosum (F). Binding of specific
antibodies was visualized with FITC-conjugated goat anti-rabbit IgG and Cy3-conjugated goat anti-mouse IgG. Blue arrows point to stratum corneum,
magenta arrows to stratum basale white arrows to fibroblasts and yellow arrows to small and middle-sized vessels. Scale bar: A–D, H 200 mm; E–G
100 mm.
doi:10.1371/journal.pone.0004416.g001
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maintained a strong staining for GS for 6 days (Figure 5D).
Simultaneously, they expressed MT (Figure 5E) evidenced by
overlapping yellow stain in merged micrograph (Figure 5F).
However, different cells could be observed which expressed GS
stronger than MT (green arrows in Figures 5D–F) and vice versa
(red arrows in Figures 5D–F). The heterogeneity in the intensity of
staining of GS and MT in neighbouring keratinocytes was
comparable with that of rat astroglial cells (cf. Figures 5F and
5C). This fact further evidenced the specificity of antigen
recognition by the anti-GS antisera and mAb against MT.
Factors influencing GS expression and activity in skin
HaCaT cells. Regulatory features of GS were investigated in
primary human keratinocytes and particularly in HaCaT cells, a
spontaneously immortalized human keratinocyte cell line [33] in
which the GS activity was only slightly higher compared to
primary human keratinocytes. Thus, the specific activity of GS in
primary human keratinocytes cultured for 24 h amounted to
4.361.8 mU/mg protein (Table 1), whereas the average GS
activity in HaCaT cells amounted to 6.864.8 mU/mg protein
(Table 1). difference between the primary cells and the HaCaT
cells was statistically insignificant due to the high variation of the
activity in this cell line.
Cell density/glutamine. Careful investigation of this
variability revealed that GS activity in the growing HaCaT cell
line was considerably influenced by the cell density as well as by
the glutamine content of the culture medium. Other differences
between the culture media seemed of less importance. When
HaCaT cells were cultivated for 24 h in the absence of Gln, GS
activity was approximately 2-fold higher than in the presence of
5 mM Gln (Figure 6A). While the higher activity in the absence of
Gln remained nearly constant for 96h, the initially low activity in
the presence of Gln slightly increased with time in parallel to the
sustained cell growth under these conditions. Accordingly, when
HaCaT cells were plated at low cell density, GS activity was very
low (Figure 6B). During prolonged cultivation (.96 h), again,
there was a steady increase in specific activity of GS as cell density
increased. After 168 h, when cell layers had reached confluence
and were highly packed, GS activity increased dramatically
(Figure 6B) indicating that intensive cell-to-cell interactions are
an important factor for high GS expression in this cell line.
Dexamethasone. As found with many cell lines [31,34,35],
the synthetic glucocorticoid dexamethasone strongly (8-fold)
induced the activity GS in HaCaT cells (Table 1). Examining of
the concentration-dependency of this effect revealed that maximal
induction in the HaCaT cells was reached above 0.1 mM
dexamethasone (Figure 6C). Partially, this induction occurred at
the transcriptional level, because GS mRNA determined by
quantitative reverse transcriptase polymerase chain reaction (RT-
PCR) increased 2.38-fold60.38 (N=3; p,0.05) after induction by
1 mM dexamethasone within 24 h (Table 1). Surprisingly, primary
Figure 2. Distribution of GS and b-catenin in normal senile
human temple skin. (A) hematoxiline staining of a skin sample.
Stratum basale can be identified by cells with prominent nuclei. (B) GS is
localized throughout the viable part of the epidermis. The highest
staining intensity can be detected at the interface of stratum
granulosum and stratum corneum. (C) Localization of b-catenin in
lower parts of the epidermis. b-catenin shows a strong membraneous
and cytoplasmic staining in stratum basale and in stratum spinosum.
Arrows in (C) point to the presence of catenin in the nucleus of
keratinocytes. Scale bar 25 mm.
doi:10.1371/journal.pone.0004416.g002
Figure 3. Expression of GS in newborn rat scalp sections CLS
microscopy of skin preparations stained for GS. (A) Representa-
tive of serial optical sections obtained by CLS microscopy of newborn
rat skin stained for GS (green). (B) Phase contrast micrograph of the field
shown in (A). (C) Wide-field fluorescence microscopy of fibroblasts in
human skin. (D, H) Representative of serial optical sections obtained by
CLS microscopy of cultured human fibroblasts stained for GS. GS was
detected using rabbit antiserum and FITC-conjugated goat anti-rabbit
IgG. (E, F) Representatives of serial optical sections obtained by CLS
microscopy of hair follicle in newborn rat skin section stained for GS. (G)
Phase contrast micrograph of the field shown in E and F. Blue arrows
point to epidermis, magenta arrows to the keratinocytes forming the
stratum basale of the epidermis, white arrows to fibroblasts, green
arrows to the outer sheet of the hair follicle, red arrows to the hair
channel. Scale bar in (A, B, D, H) 20 mm; in (C) 100 mm; in (E, F, G) 40 mm.
doi:10.1371/journal.pone.0004416.g003
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the fact that keratinocyte growth medium contains hydrocortisone
and, thus, primary cells might already reflect a somewhat induced
state remains to be determined. Since hydrocortisone is vital for
maintaining primary keratinocytes in culture, this hypothesis
cannot directly be tested experimentally.
Ammonium ions. A rather unexpected finding obtained
using HaCaT cells was that GS activity strongly increased in
response to exposure to NH4
+ ions. Depending on the specific
activity of controls an increase in GS activity, up to approx. 9-fold,
could be observed after the addition of 30 mM NH4Cl (Table 1).
Figure 6D shows the concentration-dependence of this effect. Even
in dense cultures showing a high control activity such as depicted
in concentrations as low as 5 mM NH4Cl (Figure 6D) caused a
significant increase in specific GS activity within 24 h. Generally,
exposure to high concentrations of NH4Cl led to the highest GS
activites around 80 mU/mg protein measured in HaCaT cell
cultures. Even at concentrations as high as 30 mM NH4Cl no
changes in cells size or shape were visible in bright field
microscopy. In contrast to enzyme activity, the increase in GS
mRNA over controls determined by quantitative RT-PCR under
all conditions was insignificant. For instance, in the presence of
30 mM NH4Cl the fold increase of GS mRNA amounted only to
1.4560.28 (N=4). GS activity in primary human keratinocytes
similarly responded to ammonium ions (Table 1), although the
increase was less prominent compared to the cell line. Absence of
alteration in molecular activity of the enzyme under these
conditions (not shown) excluded posttranslational modification.
These findings suggest a marked posttranscriptional influence of
NH4Cl on GS, similar to that described in skeletal muscles [36].
Lithium chloride. In order to learn more about the possible
involvement of b-catenin signalling in the regulation of GS in skin,
we exposed cultured human keratinocytes and HaCaT cells to
LiCl, a commonly used glycogen synthase kinase 3ß (GSK3b)
inhibitor [37] that is able to activate b-catenin and to induce GS in
hepatocellular populations [38,31]. As shown in Table 1, LiCl
failed to significantly induce GS in both types of cells, although
activity values tended to be slightly increased. Thus, b-catenin
Figure 4. Age-dependent distribution of GS and GFAP in rat scalp. (A–C) Double labelling of newborn (2–3-day-old) rat scalp. (A) staining for
GS (green, pAb), (B) staining for GFAP (red, mAb), (C) merge. (D–F) Double staining of adult rat scalp sections. (D) staining for GS, (E) staining for GFAP,
(F) merge. The insert in (C) shows single keratinocytes strongly stained for GS. White arrowheads in the insert point to GS-positive cells migrating
towards the outer layer of the skin. The insert in (F) shows the prominent differences in the ratio of GS and GFAP in neighboring regions of the
epidermis of adult rat skin evidenced by green, yellow or orange staining. Red arrows in (A–F) point to stratum basale, white arrows to stratum
spinosum, magenta arrows to stratum granulosum, yellow arrows to stratum corneum. (G–L) Co-expression of GS and GFAP in adult rat leg skin. (G–I)
Double labelling of skin section from the lateral surface of adult rat leg skin. (G) staining for GS (green, pAb), (H) staining for GFAP (red, mAb), (I)
merge. (J–L) Double staining of skin section from the medial surface of adult rat leg skin. (J) staining for GS, (K) staining for GFAP, (L) merge. White
arrows in (G–L) point to the portion of the skin in which GS can be barely detected, whereas red arrows point to the portion of the skin in which GS is
strongly expressed. Binding of specific antibodies was visualized with FITC-conjugated goat anti-rabbit IgG (A, D, G, J) and Cy3-conjugated goat anti-
mouse IgG (B, E, H, K). Scale bar: (A–C) 10 mm; (D–F) 20 mm.
doi:10.1371/journal.pone.0004416.g004
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levels of GS protein in keratinocytes.
Discussion
Cellular localization of GS in skin and its correlation with
neural marker proteins
The present study demonstrates the previously unknown
distribution of GS in human and rat skin. It shows unexpectedly
large stores of GS in epidermal keratinocytes in human and rat
skin sections. This study contradict to low activity of this enzyme in
rat and murine skin homogenates demonstrated in very few
reports elucidating the presence of GS in normal skin [14,16]. The
accumulation of GS in all epidermal cell layers was detected using
mAB and pAb against GS. The authenticity of antigens
recognized by pAb GS is confirmed also by heterogeneity in the
intensity and pattern of GS staining between neighboring cells and
regions of epidermis and dermis, as well as between cultured
human keratinocytes, that might be due to differences in the
individual rates of differentiation of these cells. The expression of
GS throughout all layers of the epidermis suggests its importance
for several skin-specific functions (see Table 2). Thus, the presence
of GS in stratum basale suggests its involvement in sustained
rejuvenation of keratinocyte population, its accumulation in
stratum granulosum may indicate its involvement in the
establishment of the epidermal permeability barrier, whereas its
prominent expression in the outermost layer of the epidermis, the
stratum corneum may hint at its necessity for the physical and
chemical defense [39]. The loss of these functions as observed in
inherited GS deficiency [17] could explain the severe skin
pathology associated with this disease.
GS and epidermal permeability barrier
GS is related to proteins involved in establishment of protective
barriers against external signals at the blood-tissue interfaces in
brain and liver. The present study shows that GS is essential also
for establishment of epidermal permeability barrier. The large
amount of GS throughout the epidermis and also in dermis is in
agreement with the main function of skin to control the
homeostasis of the organism. The intimate connection of Gln-
enriched proteins to an epidermal barrier function has been
proven in human skin diseases [40] and in transgenic mice
overexpressing claudin-6, i.e., tight junction protein in the
epidermis [41]. Therefore, keratinocytes of stratum granulosum
carry a particular burden, because in this layer cells synthesize lots
Table 1. Effect of NH4Cl, LiCl and dexamethasone on the
specific activity of GS in primary human keratinocytes and
HaCaT cells.
Treatment
1 Keratinocytes HaCaT cells
GS specific activity [mU/mg]
Control 4.361.8
2 6.864.8
NH4Cl (30 mM) 11.460.6* 65.166.2*
LiCl (50 mM) 7.161.6 7.761.4
dexamethasone (1 mM) 5.162.8 57.363.7*
1Cells were incubated for 24 h at the indicated concentrations for the different
stimulators.
2Values represents means6SD of 3 to 8 determinations.
*statistically different from respective controls, p,0.01
doi:10.1371/journal.pone.0004416.t001
Figure 5. Co-expression of GS and metallothionein in rat skin sections and in cultured human keratinocytes and rat brain
astrocytes. (A, B) Double-staining for GS (green) and MT (red) in newborn ratscalp sections. (B) Expression of GS (green) and MT (red) in rat scalp hair
follicle. Cell nuclei in A–L are stained with DAPI (blue). (C) Co-expression of GS (green) and MT (red) by cultured newborn rat astroglial cells. (D–F)
Expression of GS (D) and MT (E) and their co-localization (F, merge) in cultured human skin keratinocytes. GS was detected using rabbit antiserum and
FITC-conjugated goat anti-rabbit IgG, whereas MT was detected using mAb MT and Cy3-conjugated goat anti-mouse IgG. Blue arrows point to
stratum corneum, yellow arrows in (A) to stratum basale, magenta arrows to the keratinocytes forming the stratum granulosum, red arrows in A and
B to the hair channel, green arrows to the outer sheet of the hair follicle, white arrows to fibroblasts; yellow arrowheads in (B) to sweet glands. Red
arrows in (D–F) point to cells which predominantly express MT, green arrows in (D–F) point to cells which predominantly express GS. Scale bar: in (A,
D, E, F) 10 mm; in (B, C) 20 mm.
doi:10.1371/journal.pone.0004416.g005
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ation of keratinocytes into corneocytes and generation of the
stratum corneum. Many of structural proteins involved in
establishment of epidermal barrier for example involucrin,
loricrin, and filaggrin, contain a disproportionally high percentage
of Gln [41–44] and are increased during development of
epidermal barrier [41,45]. Thus, synthesis of skin proteins creates
a strong demand for enhanced intracellular pool of Gln that most
likely cannot be satisfied by diffusion of Gln from the blood
through stratum basale and stratum spinosum. Consequently, high
local production based on the predominant expression of GS in
stratum granulosum and the adjacent part of stratum corneum
may be of utmost importance to guarantee an optimal supply of
Gln.
An epidermal barrier is in part formed by tight junction
components which in adults are localized to a narrow zone of the
granular cells [46]. Strong expression of GS in stratum
granulosum and stratum corneum of young human skin and its
redistribution into the stratum granulosum and inner layers of the
epidermis in senile human skin shown in the present study might
reflect its active involvement in protection provided by tight
junctions. Indeed, GS has been shown to prevent disruption of the
tight junctions by acetaldehyde, to maintain the transepithelial
resistance and to decrease the paracellular permeability [28].
Furthermore, exposure of intestinal cell cultures to Gln influenced
the expression of functional components of tight junctions, i.e.,
claudin-1, occludin, and ZO-1 protein [29].
The timing of GS expression in keratinocytes coincides with
production of MT, another proliferation-inducing and barrier
supporting factor [47]. Presence of MT in different cell types
evidence their capacity to reflect the attack of immunologic
stressors, oxidative stress and intoxication caused by heavy metals
[48]. The co-localization of GS and MT has been shown also in
functionally active astrocytes and activated HSC [7,9,21,22]. In
the light of elevated occurrence of cadmium in the environment
and increased human use of this toxic heavy metal [49], a further
Figure 6. Regulatory features of GS in HaCaT cells. (A) Effect of Gln on the specific activity of GS. Cells were cultivated over 96 h with (squares)
and w/o (circles) 5 mM Gln. Medium was renewed every day. Each point represents the mean6SD of 3 determinations for a representative culture. (B)
Effect of cultivation time on the specific activity of GS. Cells were cultivated for the times indicated and then harvested. Culture medium was
exchanged 3 times a week. Each point represents the mean6SD of 3 determinations for a representative culture. (C) Effect of dexamethasone on the
specific activity of GS. Cells were incubated with the indicated concentrations of dexamethasone for 24 h. Each point represents the mean6SD of 3
determinations. (D) Effect of ammonium chloride on the specific activity of GS. Cells were incubated for 24 h in the presence of the indicated
concentrations of NH4Cl. Each point represents the mean6SD of 3 determinations for a representative culture. Statistically significant from controls:
*, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0004416.g006
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against cadmium-induced damage of tight junctions [50,51]. After
being trapped by metallothionein, ionic cadmium [Cd
2+] lost its
capacity to damage the tight junctions between LLC-PK1 cells
[50]. Co-production of GS and MT by young human foreskin
epidermal cells and especially by keratinocytes situated in the
stratum basale of newborn rat skin is in accordance with literature
data showing direct correlation between neural and non-neural
cell proliferation rates and concentrations of MT [23] and GS
[12,22,52].
Actin cytoskeleton plays an essential role nearly in all functions
performed by skin, i.e., cell division [53], contraction [54],
migration [55,56] and stratification of epidermis [57]. SMAA, the
marker protein of myofibroblasts, is also related to junction-
associated proteins [58,59]. In active states of the GFAP-positive
HSC, mesangial cells, astrocytes characterized by increased
capacity for proliferation and resistance to environmental insults
SMAA is contracted to the perinuclear area [23, 24] similar to that
of observed in keratinocytes. Simultaneous appearance of SMAA,
GS and MT at functionally active states of astrocytes, HSC,
mesangial cells and keratinocytes [21,23,24]. further emphasizes
our hypothesis of the commonness of mechanisms operating at the
border of different environments and tissues, in particular at the
integumentum. Functional association between actin, tight
junction, adherens junction proteins and GS were evidenced by
reduced acetaldehyde-induced dissociation of occludin, zonula
occludens-1, E-cadherin, and beta-catenin from the actin
cytoskeleton when Caco-2 cells were exposed to Gln [28]. In this
study, an indirect evidence of functional association of actin with
mechanical barrier provided by tight junction [58–60] is presented
by dense lining of actin-positive cells in stratum granulosum of
young human foreskin. A week SMAA immunoreaction and
moderate mRNA have been shown in a small number of
keratinocytes in the interscapular region of intact newborn rat
skin [61]. Furthermore, in a current study on adult murine skin we
found that the number of SMAA-synthesizing keratinocytes was
strongly dependent on the strain of mice and was sometimes lower
than in human skin (unpublished results).
Epidermal keratinocytes are faced with the complex task of
providing anti-cytotoxic and mechanical defense supported by
SMAA cytoskeleton, as well as facilitated exchange with external
environment and immune barriers supported by GFAP cytoskel-
eton. High levels of filamentous GFAP expression in differentiated
astrocytes and non-differentiated HSC and mesangial cells were
associated with cellular functions associated with facilitated
transport and down-regulation or absence of GS, MT and SMAA
[23,24,62]. Therefore, co-expression of GFAP and major
histocompatibility complex II by keratinocytes [21] on the one
hand, and of MT, SMAA and GS on the other hand, is a further
evidence of complex tasks of keratinocytes to distinguish between
external signals to be utilized from those to be blocked. Further
studies are necessary to understand the enigma of appearance of
SMAA, the marker protein of myofibroblasts and mesenchyma
cells, in epidermal keratinocytes.
Age associated changes of GS
The balance between growth and apoptosis of keratinocyte
providing continuous renewal and resistance of stratum corneum
to external signals is disturbed with age. The mechanisms involved
in this process are not well understood. Our study shows that
production of GS by skin is developmentally regulated and that
the dynamics of postnatal differentiation of GS in human and rat
skin is comparable with age-dependent changes in GS expression
in human and rat skin (Table 2). Both in humans and rats aging of
the skin led to accumulation of GS in stratum granulosum and
downregulation of the enzyme in stratum basale. Presence of GS
in newly formed corneocytes which at that time still contained
many nuclei evidenced the importance of GS for functions
performed by living cells. Likewise, in young foreskin which
showed the smallest number of stratum corneum cell layers GS
was found in all layers. By contrast, the stratum corneum of aged
human temple skin which demonstrated multiple layers of cells in
stratum corneum was devoid of GS. The data presented further
suggest that GS is always associated with developing keratinocytes
up to the stage of terminal differentiation of the corneocytes that
results in programmed cell death partially resembling apoptosis
[63,64]. The differences observed in stratum corneum cell layers
depending on location, age and among different individuals
corroborate previous findings [26] demonstrating the smallest
number of stratum corneum cell layers in genital skin compared to
that of face and scalp.
In accordance with studies demonstrating age-dependent
decrease in the permeability barrier of the skin and seized capacity
of skin stem cells for repair with age [25,65,66], strong expression
of GS in newborn rat skin stratum basale, consisting mainly of
stem cells, slightly decreased in adult animals. Also the intense
staining for GS throughout the epidermis of young human foreskin
implies high potency of this skin region for proliferation and
regeneration. The presence of b-catenin in inner layers (spinous
and granular layers) of aged skin epidermis shown herein
demonstrates the upkeeping of the stem cell pool in elderly [67].
Changes in the architecture of senile human skin were illustrated
not only by absence of GS and thickening of stratum corneum but
also by dense laying of keratinocytes intensely stained for GS in
stratum granulosum. Whether the redistribution of GS from
stratum corneum to stratum granulosum, a region enriched by
Table 2. Age- and region-dependent distribution of glutamine synthetase in human and rat skin sections.















Stratum corneum ++++ 22 ++ + + ++
Stratum granulosum ++++ ++++ + +++ ++++ ++ ++++
Stratum spinosum +++ +++ + + ++ ++ ++
Stratum basalis +++ +++ ++++ ++++ ++ ++ ++++
The cells were labelled with polyclonal antibodies against GS. The intensity of staining was estimated visually as absent (2), weak (+), moderate (++), strong (+++)o r
very strong (++++).
doi:10.1371/journal.pone.0004416.t002
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ed dehydration leading to laxity and changes in the architecture of
the skin [68] is a matter of future investigations.
Simultaneous presence of GS and b-catenin in keratinocytes of
stratum basale and stratum spinosum and the presence of
activated cytoplasmic and nuclear b-catenin in these cells shows
similarities to the regulation of GS expression in hepatocytes.
There, active Wnt/b-catenin signalling is required for initiating
GS expression [31,32,38]. Our findings concerning co-localization
of b-catenin and GS suggests that the mechanism of post
differentiation patterning recently hypothesized for liver tissue
[31] may likewise be relevant for skin. Briefly, post differentiation
patterning suggests that b-catenin signalling acts on proliferating
or differentiating cells imprinting them to express GS and
rendering this expression to be regulated by various other signals.
These features are then maintained in quiescent, post-mitotic cells
even in the absence of continuous b-catenin signalling and allow
extremely high expression levels of this enzyme [31]. Exactly this
situation seems to occur when keratinocytes terminally differen-
tiate in stratum granulosum where no activated b-catenin was
found, but the highest concentration of GS is reached.
Ammonium ions as regulators of GS activity
The regulatory mechanisms controlling the GS activity in skin
present a mixture of mechanisms controlling this enzyme in inner
organs with an unusual mode of regulation by ammonium ions,
pointing to hidden mission of this enzyme in the integumentum.
Liver and brain are the major ammonia consuming systems
metabolizing it to Gln [69]. Among mechanisms triggering blood-
brain barrier alterations in hepatic encephalopathy and its
reestablishment after reversal of fibrosis, the central place is given
to hemodynamic changes and circulating ammonia [70,71]. GS
prevents the entry of high amounts of ammonia from circulation to
brain and thus, attenuates neurotoxicity. The changes in the
distribution of this critical enzyme suggest that the glutamate-
glutamine cycle may be differentially impaired in hyperammone-
mic states [72]. Both brain and liver reacted to hyperammonemia
by down-regulation of GS [68], a response that was also found in
cultured hepatocytes [3]. In contrast, skeletal muscles react to
increase in blood ammonia level by up-regulation of GS [73]. In
skeletal muscle, enzymatic activity (but not gene) was significantly
up-regulated [36,68,73,74]. In the hyperammonemic rat muscle
ammonia levels were always increased and muscle Gln decreased,
probably indicating glutamate consumption by enhanced Gln
synthesis [75].
Recent studies showed that ammonia was present in gas
emanated from the skin surface of healthy persons and patients
with hepatic disease. The average level of ammonium ions
removed via skin correlated with that of in blood and it reached
the highest amounts in so-called skin gas collected from patients
with hepatic disease [76]. This mode of elimination of circulating
ammonia may contribute to and partially explain the large
amounts of GS in the skin. Judging from the fact that erythema
could be induced when highly ammoniacal urine was applied
exclusively to scarified skin [77], the roots of the severe skin
pathology in GS-deficiency [17] primary lay in deficit of Gln
leading to reduced production of structural proteins. In the light of
our results demonstrating the GS-activating effect of ammonia, the
removal of circulating ammonia via skin presents a natural
continuously acting mechanism of regulation of GS activity
favoring the local skin requirements for Gln in normal
physiological conditions as well as in pathologic situation. Large
amounts of GS in keratinocytes in situ and in culture and over-
activation of GS (but not mRNA) in cultured keratinocytes
exposed to ammonium ions, allows to consider the skin as
powerful ammonium detoxification pool which comes to action
during hyperammonemia. On the other hand, it is well established
that hyperammonemia may disrupt blood-brain barrier integrity
[78]. Also Madin-Darby canine kidney cells responded to elevated
extracellular NH4Cl concentrations by distinct alterations in the
architecture and transepithelial transport properties, redistribution
of occludin, a tight junction protein, and reorganization of the
actin cytoskeleton [79]. Therefore, the continuous irrigation of
normal epidermis with small amounts of circulating ammonia may
play a positive role not only in the sense of activation of GS, but
also in preservation of exchange between the skin and external
world.
Other factors regulating the GS activity
The presence of ornithine aminotransferase in skin [80] renders
it possible that a similarly efficient production chain for Gln exists
in epidermal keratinocytes as it is found in pericentral hepatocytes,
the predominant site of Gln formation in the liver [31].
Nonetheless, further mechanisms seem to exist which can enhance
GS activity, in order to match the need for an extraordinary high
Gln synthetic capacity in certain skin layers. Regulation of
keratinocytic GS by glucocorticoids and Gln shows many features
known for other cells, e.g. astrocytes [81–84]. The same is true for
regulation of GS by the density of keratinocytes. Naturally, high
density of cultured keratinocytes provides higher level of GS,
therefore of Gln, an amino acid known to induce the proliferation
of different cell types. Also GS activity of liver-derived epitheloid
cell lines and astrocytes is upregulated with increasing cell density
and peaks in confluent cultures [34,85].
Extrapolating the results obtained on cultured skin cells into in
vivo conditions allows to propose that epidermal permeability
barrier depends on Gln-induced expansion of keratinocytes that in
turn increases the density of cell sealing and logically limits the
paracellular permeability. The findings reported herein for
keratinocytes contrast with those reported for dermal fibroblasts
[86]. Thus, despite the presence of GS in many cell types of the
skin, this organ does not seem to act uniformly with respect to GS
expression and Gln synthesis, but rather shows considerable
heterogeneity tailored to serve complex skin-specific functions.
Concluding remarks
The present study comprises several experiments opening a new
view on the physiological importance and multiple roles of GS in a
complex series of events foreseen by an epidermal program aiming
at the establishment of epidermal permeability barrier supported
by sustained rejuvenation, differentiation, transepithelial resis-
tance, detoxification, immune protection and cell-to-cell interac-
tions. Since GS expression in skin is developmentally regulated, it
may, thus, additionally be involved in mechanisms regulating the
balance between cellular growth and programmed cell death.
Our study suggests that the apparently low activity of this
enzyme in skin was previously underestimated resulting from
measurements of average enzymatic activity in whole skin
homogenates containing both enzymatically active and silent
GS. These studies neglect the local skin-specific cellular functions
and undervalued the capacity of keratinocytic GS for being
modulated in health and disease. The results reported here in
conjunction with literature data open new perspectives in the
investigation of skin cell functions in healthy and pathological
states. They call for further elucidation of the functional
predestination of large stores of immunoreactive but enzymatically
silent GS in epidermis particularly in stratum corneum as well as
of regulatory mechanisms controlling its enzymatic activity, and
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the epidermal permeability barrier. Thus our results favor not only
local specific functions of GS comprising the production of excess
Gln for regional biosynthetic purposes, they also suggest a life-
essential role of keratinocytic GS for whole organism in health and
disease.
Materials and Methods
Reagents. Dexamethasone, Gln, penicillin, streptomycin,
POD-extravidin, diaminobenzidine, aminotriazole, goat serum
and Triton X-100 were products of Sigma (Taufkirchen,
Germany). NH4Cl, ethylenediaminetetraacetic acid (EDTA),
H2O2, Roti-Histokit, Tween 20 were purchased from Roth
(Karlsruhe, Germany). Oligo(dT) primer, primer for GS and b-
actin, Superscript II Reverse Transcriptase, SeeBlueH Pre-Stained
protein standards were products of Invitrogen GmbH (Karlsruhe,
Germany). The culture medium Dulbecco’s modified Eagles
medium (DMEM) and fetal calf serum (FCS) were purchased
from GIBCO (Eggenstein, Germany). Keratinocyte growth
medium and human epidermal growth factor (Clonetics, USA),
trypsin and the Light Cycler FastStart DNA Master+SYBR Green
I Kit were products of Roche Diagnostics GmbH (Mannheim,
Germany). Vectashield mounting medium was purchased from
Vector Laboratories (Burlingame, CA, USA). RNA isolation was
performed using the Nucleo Spin RNA II Kit from Macherey-
Nagel (Du ¨ren, Germany). Cell culture material was obtained from
Techno Plastic Products AG (Trasadingen, Switzerland) as well as
from Greiner Bio-One GmbH (Frickenhausen, Germany).
Antibodies. Monoclonal mouse anti-GS and monoclonal
mouse anti-b-catenin antibodies were products of Becton,
Dickinson and Company Transduction Laboratories (Heidelberg,
Germany). Goat anti-mouse IgG Fab–POD fragment was purchased
from Sigma (Taufkirchen, Germany). Biotinylated goat anti-mouse
IgG-Fc antibody and sheep anti-mouse IgG Fab-AP were products of
Chemicon International Ltd. (Hampshire, United Kingdom).
Monoclonal anti-GFAP (clone GF 12.24) and monoclonal antibody
against SMAA (anti-SMAA, clone ASM-1) were products of Progen
Biotechnik GmbH (Heidelberg, Germany). The monoclonal
antibody against Cd/Zn-inducible MT-1 was a generous gift of
P r o f .U .W e s e r( U n i v e r s i t yo fT u ¨bingen, Germany). Polyclonal anti-
GS antibody against pig brain GS was raised in the laboratory of Dr.
Jaenicke [87]. Fluorescein isothiocyanate (FITC)-conjugated goat
anti-rabbit IgG and Cy3-conjugated goat anti-mouse IgG were from
Dianova Jackson Immuno-research (West Grove, USA).
Animals. New-born and adult Sprague-Dawley rats (250 to
300g) were obtained from Charles River (Sulzfeld, Germany) and
maintained at the central animal facility according to institutional
guidelines for ethical care of animals. Samples of rat skin were
prepared from the scalp of newborn rats after extirpation of the brain
which was used for the preparation of astroglial primary cultures.
Human skin. Samples of human foreskin were obtained from
the Childrens Hospital of the University of Leipzig with consent
from patients who underwent circumscission (phimosis) and
samples of temple skin of 70-year-old male (healthy border of a
basal cell carcinoma) from the Dermatology department of the
University of Leipzig. All human skin samples were taken after
written consent of the patients and in accordance with the
principles and under the license of the Ethic Commission of the
University of Leipzig.
Cell culture
Primary keratinocyte culture. Primary normal human
epidermal keratinocytes were isolated from the foreskins of 2–
8 year old children according to the methods described by Zellmer
and Reissig [88]. Briefly, the cells were seeded in Petri dishes and
were grown in serum-free keratinocyte growth medium
supplemented with 0.15 mM CaCl2, 0.1 mg/ml human epidermal
growth factor, 0.5 mg/ml hydrocortisone, 5 mg/ml insulin, 30 mg/
ml bovine pituitary extract, 50 mg/ml gentamycin, and 50 mg/ml
amphotericin. Cultures were terminated at day 7 as described
previously [21].
Keratinocyte cell line. HaCaT cells [33] were cultivated
using DMEM medium supplemented with 2 mM glutamine, 10%
FCS, 50 U/ml penicillin and 37.5 U/ml streptomycin in 75 cm
2
cell culture flasks. For sub-cultivation the cells were incubated with
Hanks balanced solution without calcium, supplemented with
0.05% EDTA for 20 minutes. Then, cells were harvested using a
Hanks solution composed of 0.05% trypsin and 0.025% EDTA
and suspended in supplemented DMEM.
Fibroblasts. Monolayers of normal human dermal
fibroblasts from the foreskins of 2–8 year old children were
obtained from explant cultures of de-epidermized skin and
cultured in DMEM containing 10% heat-inactivated FCS
(Gibco, Karlsruhe, Germany), 50 mg/ml L-ascorbic acid, 100
U/ml penicillin, and 100 mg/ml streptomycin sulphate, as
previously described [89]. The fibroblast cultures were kept in
an incubator with 5% CO2 in air (95% humidity) at 37 uC.
Cultures were terminated at day 1 and 3 in culture as described
previously [21].
Astroglial cells. Rat astroglia-rich primary cultures were
prepared from brains of newborn animals as described elsewhere
[90].
Immunohistochemistry and Immunocytochemistry
Indirect double- and mono immunofluorescence
studies. Unfixed 7 mm cryostat human and rat skin sections,
cultured human keratinocytes and fibroblasts, as well as cultured
rat astroglial cells were prepared as described previously [91].
After fixation in methanol (220uC), the cells and tissue slices were
washed with phosphate buffered saline (PBS) at room temperature
(RT). In monolabelling studies, the sections and cells were exposed
to pAb anti-GS (dilution 1:100) only. In double-immunolabelling
studies, mixtures of pAb anti-GS with mAb against GFAP (dilution
1:100) or mAb against Cd/Zn-inducible MT-1 (1.7 mg/ml,
dilution 1:100) [7,23,92], or mAb against SMAA (dilution 1:100)
were applied. After 2 h incubation at RT, specimens were washed
and exposed for 1 h at RT to a mixture of the secondary
antibodies: FITC-conjugated anti-rabbit IgG (dilution 1:100) and
Cy-3 conjugated anti-mouse IgG (dilution 1:800). All antibodies
were diluted with PBS. Subsequently, the cells and tissues were
washed with PBS containing Triton X-100 and mounted in
Vectashield mounting medium with or w/o DAPI.
Immunochemical detection of GS and b-catenin. Human
skin samples were stored at 280 uC. Slices were cut and fixed in
3.5% paraformaldehyde immediately before staining. For the
detection of b-catenin the tissue slices were permeabilized with
0.1 M Tris-borate buffer (pH 7.4) containing 0.2% Tween20 and
the endogenous peroxidase activity was destroyed by incubation
with 0.3% H2O2. The slices were incubated with monoclonal
mouse anti-b-catenin antibody over night. After washing the
secondary biotinylated goat anti-mouse IgG-Fc antibody was
added for 1 h at RT followed by addition of the POD-Extravidin
complex for 30 min. Staining was performed in 0.1 M Tris-HCl
buffer (pH 7.6), composed of 0.05% diaminobenzidine, 2%
aminotriazole and 0.033% H2O2. Finally the slices were
dehydrated and embedded using Roti-Histokit. For the detection
of GS the tissue slices were fixed and permeabilized as described
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with 10% goat serum and the slices were incubated with
monoclonal mouse anti-GS antibody at 4uC over night.
Subsequently the slices were washed and incubated with a goat
anti-mouse IgG Fab–POD fragment. Staining and embedding was
performed using Roti-Histokit. Nuclei were stained by immersion
in Haemalaun solution for 2 min followed by washing for 10 min
with tap water.
Microscopy
Bright field microscopy. POD-labelled sections were
visualized using a Leica DM5000 B microscope (Leica, Bensheim,
Germany) equipped with a HCX PlanApo 406/0.75 objective and
a Leica FX 350 camera using the LAS software of Leica.
Fluorescence microscopy. FITC-conjugated anti-rabbit
IgG-labelled and Cy-3 conjugated anti-mouse IgG-labelled
sections and cells were examined using:
1. Wide-field fluorescence microscope BX 51 (Olympus Optical
Co. Europe, Hamburg, Germany) with UplanFI 206/0.5 Ph1,
UPlanFI 106/0.30 Ph1, and UPlanFI 406/0.75 Ph2 objec-
tives. Images were taken with the digital camera F-View II (Soft
Imaging System, Leinfelden-Echterdingen, Germany) and data
were processed with AnalySIS DOKUH (Soft Imaging System).
2. Confocal laser scanning microscope Leica SL equipped with an
argon/krypton laser (Leica Lasertechnik, Heidelberg, Ger-
many). To improve the signal-to-noise ratio, 8 scans of one
focal plane were averaged. The confocal image data were
obtained using a PLANAPO 636, 1.32 NA oil immersion
objective and confocal laser scanning microscope software
(Leica Lasertechnik), and processed with Adobe Photoshop 7.0
software (Adobe Systems Inc., Mountain View, CA, USA).
Determination of glutamine synthetase activity
Specific GS activity was determined by the method of Levintow
[93] with minor modifications described by Gebhardt and
Williams [94]. Briefly, 7.5610
6 cells were seeded into 6 well
plates and cultivated in 1 ml medium at 37uC and 5% CO2. After
washing with Hanks balanced solution the cells were harvested
using a rubber police man, disrupted by sonication (Sonoplus,
Bandelin, Germany) and the protein concentration was deter-
mined according to Bradford [95] in order to calculate the specific
GS activity.
Quantitative PCR
Cells were washed twice with Hanks balanced salt solution. Total
RNA was isolated using the Nucleo Spin RNA II Kit according to
the manufacturer description which included DNase I digestion.
Onemg of totalRNAwas reverse transcribed using oligo(dT)primer
and Superscript II Reverse Transcriptase. The cDNA was diluted
1/10 and 3 ml were used for amplification of GS and b-actin as
internal controlusing the Light Cycler FastStart DNAMasterPLUS
SYBR Green I Kit. The following primers were used for GS: 59-
CACTACCGGGCCTGCTTGTAT-39 (forward primer) and 59-
GCATGGCCTTGGTGCTAAAGTTG-39 (reverseprimer),forb-
actin: 59-AGAAAATCTGGCACCACACC-39 (forward primer)
and 59-CTCCTTAATGTCACGCAC-GA-39 (reverse primer).
The PCR reactions were performed in duplicate in 20 ml volume
containing 3 ml cDNA, 0.5 mM of each primer, and 4.0 ml
56Master Mix. PCR products were quantified using a Light Cycler
2.0(Roche Diagnostics GmbH, Mannheim, Germany) accordingto
the following protocol: after heating for 10 min at 95uC,
amplification was performed by 40 cycles of 3 s at 94uC, 5 s at
56uC and 20 s at 72uC, followed by a melting curve analysis. The
fold induction of GS mRNA was calculated using the Relative
Quantification Method of the Light Cycler 4.05 software (Roche
Diagnostics GmbH).
Statistical evaluation
Enzymatic determination or quantitative RT-PCR measure-
ment were repeated independently at least 3 times as stated in the
legends of figures and tables. Data reported represent mean-
s6standard deviation (SD). Statistical evaluation was performed
using Student’s t-test.
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